We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TNON:NASDAQTenon Medical, Inc. Analysis

Data as of 2026-09-06 - not real-time

$3.72

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Tenon Medical, Inc. is bearish at $3.72, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 44.1%. RSI sits at 37.1, which reads as approaching oversold, and MACD momentum is bearish. Watch $3.62 as support and $17.84 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 1092.9% above where the shares trade now. Revenue is growing at 126.8% on a -257.9% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 300.0%, a beta of 0.98 and a maximum drawdown of 91.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 2 out of 10.

Top Market Events

~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~~ Second Quarter Gross Profit of...LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc.Tenon Medical Inc. TNON shares surged 82.86% to $0.64 after the bell on Thursday. According to Benzinga Pro data, the...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 23.72
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 23.72
  • Analyst targets imply +1092.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -257.9%
  • Analyst targets imply +1092.9% versus the current price
  • Negative return on equity of -551.2%

Key Metrics & Analysis

Financial Health

Revenue Growth126.80%
Profit Margin-257.85%
P/E Ratio-0.3
ROE-551.19%
ROA-71.98%
P/B Ratio-0.3
Op. Cash Flow$-11766000
Free Cash Flow$-6116125
Industry P/E30.6

Technical Analysis

TrendBearish
RSI37.1
Support$3.62
Resistance$17.84
MA 20$5.64
MA 50$7.13
MA 200$23.72
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Target Price$44.38
Upside/Downside1092.88%
GradeFair
TypeGrowth

Risk Assessment

Beta0.98
Volatility300.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.